BMS is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have launched with big ...

Continuing the upmanship battle in expanding the use of GLP-1 drugs beyond diabetes and obesity, Novo Nordisk has released ...

In today’s Pharmaceutical Executive Daily, we explore how AI is disrupting higher education and career pathways, AllRock ...

Olga Berson of Thompson Coburn LLP discusses opportunities as well as intellectual property pitfalls for sovereign wealth ...

Shares of Verrica Pharmaceuticals (NASDAQ:VRCA) jumped 27% on Friday after the biotech said its partner Torii Pharmaceutical ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

KalVista Pharmaceuticals showed 0% earnings growth in the latest quarterly report. Sales increased 0%. The company earns the ...

As of Sept. 18, here’s how the five richest physicians rank, per Forbes: 1. Thomas Frist Jr., MD, and family Net worth: $32.2 billion Dr. Frist co-founded HCA Healthcare with his father in 1968. While ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Former Pfizer, BenevolentAI, Incyte, and AMAG executives join to strengthen clinical, technology, financial, and scientific leadership as company scales ...

Bolstered by world-class centers of learning such as Harvard University and the Massachusetts Institute of Technology, Boston ...

Healthcare heavy weight Pro Medicus (ASX:PME) also climbed 5.7% on no fresh news, Clarity Pharmaceuticals (ASX:CU6) added 6.2 ...